Summary by Futu AI
On April 30, 2024, bluebird bio, Inc. amended its Loan and Security Agreement (LSA) with Hercules Capital, Inc. and other lenders. This amendment is in response to the company's delay in filing its Annual Report on Form 10-K for 2023 and its Quarterly Report for Q1 2024 due to the restatement of its financials for 2022 and the first three quarters of 2023. The amendment includes revised financial reporting metrics and extended deadlines for the company to provide its financial statements for the year ended December 31, 2023, and for the quarter ended March 31, 2024. The company has stated that the late filings will not be considered a violation of its legal compliance obligations, provided the documents are filed by the new deadlines. The announcement also contains forward-looking statements regarding the company's expectations for filing the delayed reports and its performance under the LSA.